Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects*
• Biopsy
• Carcinoma, Renal Cell / complications*
• Carcinoma, Renal Cell / drug therapy*
• Drug Eruptions / etiology*
• Humans
• Kidney Neoplasms / drug therapy*
• Langerhans Cells / pathology
• Male
• Middle Aged
• Nivolumab
• Psoriasis / chemically induced*
• Psoriasis / pathology
• Psoriasis / physiopathology
• Skin / pathology
• T-Lymphocytes / pathology
• Treatment Outcome